<?xml version="1.0" encoding="ISO-8859-1"?>
<entity-relation-data lastUpdate="2023-03-27 16:35:52" record="18253" source="Espacenet">
	<entities>
		<entity ref="Patent18253" type="Patent">
			<semanticIdentifier>brcris::801a079811774534e490c8ff9d211cd5</semanticIdentifier>
			<semanticIdentifier>docdb::BR102019013454A2</semanticIdentifier>
			<semanticIdentifier>epodoc::BR102019013454</semanticIdentifier>
			<semanticIdentifier>docdb::BR102019013454A</semanticIdentifier>
			<semanticIdentifier>epodoc::BR20191013454</semanticIdentifier>
			<semanticIdentifier>original::102019013454</semanticIdentifier>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=102019013454"/>
			<field name="identifier.lattes" value="4178667286777514"/>
			<field name="identifier.espacenet" value="102019013454"/>
			<field name="kindCode" value="A2"/>
			<field name="title.espacenet" value="uso de composto derivado de pirimidobenzimidazol"/>
			<field name="title.lattes" value="USO DE COMPOSTO DERIVADO DE PIRIMIDOBENZIMIDAZOL"/>
			<field name="depositDate" value="2019-06-27"/>
			<field name="publicationDate" value="2021-01-05"/>
			<field name="countryCode" value="BR"/>
			<field name="inventor" value="GUIDO LENZ"/>
			<field name="inventor" value="JESSICA GONCALVES AZEVEDO"/>
			<field name="inventor" value="MARCIA ROSANGELA WINK"/>
			<field name="inventor" value="NILO ZANATTA"/>
			<field name="inventor" value="SIMONE SCHNEIDER AMARAL"/>
			<field name="applicant" value="FUNDACAO UNIVERSIDADE FEDERAL DE CIENCIAS DA SAUDE DE PORTO ALEGRE"/>
			<field name="applicant" value="UNIVERSIDADE FEDEERAL DE SANTA MARIA - UFSM"/>
			<field name="applicant" value="UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL - UFRGS"/>
			<field name="classification.ipc">
				<field name="sequence" value="1"/>
				<field name="text" value="C07D487/04AI"/>
				<field name="section" value="C"/>
				<field name="class" value="07"/>
				<field name="subclass" value="D"/>
				<field name="group" value="487"/>
				<field name="subgroup" value="04AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="2"/>
				<field name="text" value="A61K31/519AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="31"/>
				<field name="subgroup" value="519AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="3"/>
				<field name="text" value="A61P35/00AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="35"/>
				<field name="subgroup" value="00AI"/>
			</field>
			<field name="abstract.espacenet" value="uso de composto derivado de pirimidobenzimidazol a presente invenção descreve o uso de compostos derivados de pirimidobenzimidazol para preparar de um medicamento para tratar câncer, e mais especificamente o uso do composto para preparar um medicamento para o tratamento de melanoma. mais especificamente, o composto é selecionado do grupo consistindo de 4-fenil-pirimido[1,2-a]benzimidazol-2(1h)-ona; 4-(3- hidroxipropil)pirimido[1,2-a]benzimidazol-2(1h)-ona; 2,3,4,3a,5,11a-hexaedro-4- oxo-furano[2 ,3 ;6,5]pirimido[1,2-a]benzimidazol; pirimido[1,2-a]benzimidazol2(1h)-ona; 4-metil-2-(trifluormetil)-pirimido[1,2-a]benzimidazol; 2-(trifluormetil)- pirimido[1,2-a]benzimidazol e 4-fenil-2-(trifluormetil)-pirimido[1,2- a]benzimidazol. a presente invenção se situa nos campos da química, farmácia e medicina."/>
			<field name="originatesFrom" value="74502006"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102019013454"/>
				<field name="kind" value="A2"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR102019013454"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102019013454"/>
				<field name="kind" value="A"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR20191013454"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="original"/>
				<field name="country" value=""/>
				<field name="number" value="102019013454"/>
				<field name="kind" value=""/>
			</field>
		</entity>
		<entity ref="Person12631" type="Person">
			<semanticIdentifier>lattes::4178667286777514</semanticIdentifier>
			<field name="identifier.lattes" value="4178667286777514"/>
			<field name="name" value="Guido Lenz"/>
		</entity>
		<entity ref="OrgUnit9845" type="OrgUnit">
			<semanticIdentifier>brcris::f899f1377c8a2fc052b1ab8f3940b1ec</semanticIdentifier>
			<field name="name" value="FUNDACAO UNIVERSIDADE FEDERAL DE CIENCIAS DA SAUDE DE PORTO ALEGRE"/>
		</entity>
	</entities>
	<relations>
		<relation fromEntityRef="Patent18253" toEntityRef="Person12631" type="Inventor"/>
		<relation fromEntityRef="Patent18253" toEntityRef="OrgUnit9845" type="Applicant"/>
	</relations>
</entity-relation-data>
